Nanotechnology Now - Press Release: BioForce Nanosciences Holdings, Inc. Announces Notice of Allowance for Its Sindex Chip Patent

Home > Press > BioForce Nanosciences Holdings, Inc. Announces Notice of Allowance for Its Sindex Chip Patent

Abstract:
BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), a company focused on the development and commercialization of nanotech tools and solutions for the life sciences, announced today that it has received Notice of Allowance from the United States Patent Office for Sindex(tm) chips. Sindex(tm) chips are indexed silicon substrates that serve as the basis for a host of ultraminiaturized molecular tests. As an example, BioForce researchers have developed a cancer biomarker screen that requires only four cells using the Sindex(tm) chip. They are the perfect complement to the BioForce Nano eNabler(tm) bench top molecular printer because their indexing system allows users to map the locations of microscopic biological test sites and easily find them for analysis. The Nano eNabler(tm) is being used at elite academic institutions around the world such as Harvard Medical School and Johns Hopkins University for research and development of novel nanotech applications.

BioForce Nanosciences Holdings, Inc. Announces Notice of Allowance for Its Sindex Chip Patent

AMES, IA | Posted on October 25th, 2007

Michael Lynch, co-inventor and Product Manager for the Nano eNabler(tm) system said, "The Nano eNabler creates extremely small features on surfaces for research and development in cell biology, neuroscience, tissue engineering and biosensing. As we make progress in miniaturization of biomedical tests, the capabilities of consumable BioForce products like the Sindex(tm) chip become increasingly important."

Dr. Juntao Xu, co-inventor, stated, "We designed Sindex chips to be as simple, yet useful as possible. As research and diagnostics transition from the classical laboratory environment to microscale devices, products like the Sindex(tm) chip will lead to biomedical testing being carried out at your home using a tiny amount of body fluid or just a few, painlessly obtained cells. We at BioForce are striving to be at the forefront of this revolution."

####

About BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life sciences. BioForce's flagship product, the Nano eNabler(tm) molecular printer, gives the Company a platform for development and discovery. BioForce technology is being used in sensor functionalization; patterning and cell adhesion; and printing proteins to guide neural cell growth. For more information, visit http://www.bioforcenano.com or call 515-233-8333.

This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in BioForce Nanosciences' most recent filings with the Securities and Exchange Commission. BioForce Nanosciences' actual results could differ materially from such forward-looking statements. BioForce assumes no duty to update these statements at any future date.

For more information, please click here

Contacts:
BioForce Nanosciences Holdings, Inc.
Greg Brown, CFO
515-233-8333 ext. 118

RedChip Companies, Inc.
Investor Relations
Dave Gentry
1-800-REDCHIP (733-2447) ext. 104

http://www.redchip.com